Mahkam Zanganeh, Co-CEO: Summit Therapeutics SMMT Buy · Filed 25/10/23

Trade details

Type: Insider buy
Amount: $499,983.2
Shares · price: 26,680 sh · $18.74 a share
Held after: 76,680 sh
Stock: Summit Therapeutics SMMT
Person: Mahkam ZanganehCo-CEO
Trade date: 25/10/21
Filed: 25/10/23
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +53.4%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/21~25/11/20

Mahkam Zanganeh's recent trades

Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$50M
3,810,000 sh
$50M
Filed 06/12
Traded 06/12
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$5.9M
333,394 sh
$5.9M
Filed 25/09/11
Traded 25/09/10
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$90.4K
5,000 sh
$90.4K
Filed 25/09/11
Traded 25/09/11
Mahkam ZanganehCEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$127.7K
34,321 sh
$127.7K
Filed 24/03/27
Traded 24/03/27

Mahkam Zanganeh, CEO — bought $500K of Summit Therapeutics SMMT · 26,680 sh @ $18.74 | Whalegun